Adam D. Toll

567 total citations
26 papers, 376 citations indexed

About

Adam D. Toll is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Adam D. Toll has authored 26 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Adam D. Toll's work include Pancreatitis Pathology and Treatment (6 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). Adam D. Toll is often cited by papers focused on Pancreatitis Pathology and Treatment (6 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). Adam D. Toll collaborates with scholars based in United States, Switzerland and Canada. Adam D. Toll's co-authors include Jonathan I. Epstein, Agnieszka K. Witkiewicz, Charles J. Yeo, Ralph H. Hruban, Gene Gulati, Syed Z. Ali, Juan Palazzo, Marluce Bibbo, Abhijit Dasgupta and Jonathan R. Brody and has published in prestigious journals such as The American Journal of Surgical Pathology, Radiographics and Urology.

In The Last Decade

Adam D. Toll

24 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam D. Toll United States 12 159 118 91 81 81 26 376
Pieter‐Jan Cuyle Belgium 10 146 0.9× 106 0.9× 72 0.8× 69 0.9× 51 0.6× 22 345
Polly W.Y. Lam China 10 184 1.2× 127 1.1× 84 0.9× 62 0.8× 80 1.0× 12 385
Hideto Itoh Japan 9 137 0.9× 110 0.9× 46 0.5× 138 1.7× 38 0.5× 23 339
Haojun Xie China 10 112 0.7× 105 0.9× 77 0.8× 98 1.2× 36 0.4× 22 376
Byron E. Crawford United States 11 104 0.7× 63 0.5× 88 1.0× 124 1.5× 52 0.6× 25 337
Meng‐Shu Hsieh Taiwan 10 135 0.8× 91 0.8× 95 1.0× 122 1.5× 64 0.8× 12 364
Anne E. Busseniers United States 7 75 0.5× 149 1.3× 43 0.5× 27 0.3× 30 0.4× 9 387
Seyed Reza Fatemi Iran 14 216 1.4× 105 0.9× 90 1.0× 104 1.3× 68 0.8× 56 473
Francesca Pizzagalli Italy 7 77 0.5× 160 1.4× 135 1.5× 67 0.8× 55 0.7× 7 362
Takahiro Tomino Japan 10 87 0.5× 92 0.8× 51 0.6× 47 0.6× 57 0.7× 42 284

Countries citing papers authored by Adam D. Toll

Since Specialization
Citations

This map shows the geographic impact of Adam D. Toll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam D. Toll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam D. Toll more than expected).

Fields of papers citing papers by Adam D. Toll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam D. Toll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam D. Toll. The network helps show where Adam D. Toll may publish in the future.

Co-authorship network of co-authors of Adam D. Toll

This figure shows the co-authorship network connecting the top 25 collaborators of Adam D. Toll. A scholar is included among the top collaborators of Adam D. Toll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam D. Toll. Adam D. Toll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuan, Sean X. Zhang, Adam D. Toll, et al.. (2019). Pleural fluid secondary to pulmonary cryptococcal infection: a case report and review of the literature. BMC Infectious Diseases. 19(1). 710–710. 10 indexed citations
2.
Olson, Matthew T., Deidra Kelly, Toby C. Cornish, et al.. (2014). Reproducibility of the Johns Hopkins Hospital template for urologic cytology samples. Journal of the American Society of Cytopathology. 3(3). 156–164. 11 indexed citations
3.
Toll, Adam D. & Zahra Maleki. (2014). Cytomorphology of non‐small cell lung carcinoma with anaplastic lymphoma kinase gene rearrangement. Diagnostic Cytopathology. 43(1). 8–15. 6 indexed citations
4.
Toll, Adam D. & Syed Z. Ali. (2013). Urinary Cytomorphology and Clinical Correlates of Prostatic Small Cell Neuroendocrine Carcinoma. Acta Cytologica. 57(5). 495–500.
5.
Toll, Adam D., Paul E. Wakely, & Syed Z. Ali. (2013). Acral Myxoinflammatory Fibroblastic Sarcoma: Cytopathologic Findings on Fine-Needle Aspiration. Acta Cytologica. 57(2). 134–138. 6 indexed citations
6.
Toll, Adam D. & Syed Z. Ali. (2013). Urinary Cytopathology in Primary Bladder Amyloidosis. Acta Cytologica. 57(3). 271–275. 2 indexed citations
7.
Toll, Adam D., Ralph H. Hruban, & Syed Z. Ali. (2013). Acinar Cell Carcinoma of the Pancreas: Clinical and Cytomorphologic Characteristics. The Korean Journal of Pathology. 47(2). 93–93. 24 indexed citations
8.
Toll, Adam D., Deidra Kelly, & Zahra Maleki. (2013). Utility of P16 expression and Ki‐67 proliferation index in ASCUS and ASC‐H pap tests. Diagnostic Cytopathology. 42(7). 576–581. 7 indexed citations
10.
Neste, Leander Van, Joseph Bigley, Adam D. Toll, et al.. (2012). A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection. BMC Urology. 12(1). 16–16. 38 indexed citations
11.
Toll, Adam D. & Jonathan I. Epstein. (2012). Invasive Low-Grade Papillary Urothelial Carcinoma. The American Journal of Surgical Pathology. 36(7). 1081–1086. 22 indexed citations
12.
Feld, Rick, et al.. (2011). AIRP Best Cases in Radiologic-Pathologic Correlation: Spindle Cell Carcinoma of the Esophagus. Radiographics. 31(7). 2035–2039. 1 indexed citations
13.
Toll, Adam D., Abhijit Dasgupta, Magdalena Potoczek, et al.. (2010). Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma. Human Pathology. 41(9). 1205–1209. 55 indexed citations
14.
Chew, Hall F., et al.. (2010). Post-traumatic Fungal Keratitis Caused by Carpoligna sp.. Cornea. 29(4). 449–452. 15 indexed citations
15.
Toll, Adam D. & Marluce Bibbo. (2010). Identification of Gastrointestinal Contamination in Endoscopic Ultrasound–Guided Pancreatic Fine Needle Aspiration. Acta Cytologica. 54(3). 245–248. 6 indexed citations
16.
Toll, Adam D., Terry Hyslop, Edward Pequignot, et al.. (2010). Prognostic significance of high‐grade dysplasia in colorectal adenomas. Colorectal Disease. 13(4). 370–373. 31 indexed citations
17.
Toll, Adam D., Agnieszka K. Witkiewicz, & Marluce Bibbo. (2009). Expression of K Homology Domain Containing Protein (KOC) in Pancreatic Cytology with Corresponding Histology. Acta Cytologica. 53(2). 123–129. 12 indexed citations
18.
Toll, Adam D., Donald G. Mitchell, Charles J. Yeo, Ralph H. Hruban, & Agnieszka K. Witkiewicz. (2009). Acinar Cell Carcinoma With Prominent Intraductal Growth Pattern. International Journal of Surgical Pathology. 19(6). 795–799. 19 indexed citations
19.
Toll, Adam D., et al.. (2009). Establishing the Purity of Mononuclear Cell Preparations Using Morphology and Flow Cytometry. The Medicine Forum.
20.
Toll, Adam D., et al.. (2009). Repression of E-Cadherin by the Polycomb Group Protein EZH2 in Pancreatic Cancer. The Medicine Forum. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026